Securing access to effective antibiotics for current and future generations. Whose responsibility?

References

• Fletcher C. First clinical use of penicillin. BMJ (Clin Res Ed). 1984;289:1721–3.
   Google Scholar
• Mammina C, Bonura C, Di Bernardo F, Aleo A, Fasciana T, Sodano C, et al. Ongoing spread of colistin-resistant Klebsiella pneumonia in different wards of an acute general hospital, Italy, June to December 2011. Euro Surveill. 2012;17:pii=20248.
   Google Scholar
• Marchaim D, Chopra T, Pogue JM, Perez F, Hujer AM, Rudin S, et al. Outbreak of colistin-resistant, carbapenem-resistant Klebsiella pneumoniae in metropolitan Detroit, Michigan. Antimicrob Agents Chemother. 2011;55:593–9.
   PubMed Web of Science ®Google Scholar
• Nordberg V, Quizhpe Peralta A, Galindo T, Turlej-Rogacka A, Iversen A, Giske C, et al. High proportion of intestinal colonization with successful epidemic clones of ESBL-producing Enterobacteriaceae in a neonatal intensive care unit in Ecuador. PLoS ONE. 2013;8:e76597.
   Google Scholar
• Gyansa-Lutterodt M. Antibiotc resistance in Ghana. Lancet Infect Dis. 2013;13:1006–7.
   PubMed Web of Science ®Google Scholar
• Blomberg B, Jureen R, Manji K, Tamim B, Mwakagile D, Urassa W, et al. High rate of fatal cases of pediatric septicemia caused by Gram-negative bacteria with extended-spectrum beta-lactamases in Dar es Salaam, Tanzania. J Clin Microbiol. 2005;43:745–9.
   PubMed Web of Science ®Google Scholar
• Kayange N, Kamugisha E, Mwizamholya DL, Jeremiah S, Mshana SE. Predictors of positive blood culture and deaths among neonates with suspected neonatal sepsis in a tertiary hospital, Mwanza-Tanzania. BMC Pediatr. 2010;10:39.
   PubMed Web of Science ®Google Scholar
• Laxminarayan R, Duse A, Wattal C, Zaidi AK, Wertheim HF, Sumpradit N, et al. Antibiotic resistance-the need for global solutions. Lancet Infect Dis. 2013;13:1057–98.
   PubMed Web of Science ®Google Scholar
• Allegranzi B, Bagheri Nejad S, Combescure C, Graafmans W, Attar H, Donaldson L, et al. Burden of endemic health-care associated infection in developing countries: systematic review and meta-analysis. Lancet. 2011;377:228–41.
   PubMed Web of Science ®Google Scholar
• Zaidi AK, Huskins WC, Thaver D, Bhutta ZA, Abbas Z, Goldman DA, et al. Hospital-acquired neonatal infections in developing countries. Lancet. 2005;365:1175–88.
   PubMed Web of Science ®Google Scholar
• Smith R, Coast J. The true cost of antimicrobial resistance. BMJ. 2013;346:f1493.
   PubMed Web of Science ®Google Scholar
• Phumart P, Phodha P, Thamlikitkul P, Riewpaiboon P, Prakongsai P. Health and economic impacts of antimicrobial resistant infections in Thailand: a preliminary study. J Health Syst Res. 2012;6:352–60.
   Google Scholar
• Moberg C. René Dubos: a harbinger of microbial resistance to antibiotics. Microb Drug Resist. 1996;2:287–97.
   PubMed Web of Science ®Google Scholar
• Freire-Moran L, Aronsson B, Manz C, Gyssens IC, So AD, Monnet DL, et al. Critical shortage of new antibiotics in development against multidrug-resistant bacteria. Time to react is now. Drug Resist Updat. 2011;14:118–24.
   PubMed Web of Science ®Google Scholar
• Mölstad S, Erntell M, Hanberger H, Melander E, Norman C, Skoog G, et al. Sustained reduction of antibiotic use and low bacterial resistance: 10-year follow-up of the Swedish Strama programme. Lancet Infect Dis. 2008;8:125–32.
   PubMed Web of Science ®Google Scholar
• Molstad S, Cars O, Struwe J. Strama--a Swedish working model for containment of antibiotic resistance. Euro Surveill. 2008;13:pii=19041.
   Google Scholar
• Hanberger H, Skoog G, Ternhag A, Giske CG. Antibiotic consumption and antibiotic stewardship in Swedish hospitals. Ups J Med Sci; 2014;119:154–61.
   PubMed Web of Science ®Google Scholar
• Cars O, Hedin A, Heddini A. The global need for effective antibiotics - moving towards concerted action. Drug Resist Updat. 2011;14:68–9.
   PubMed Web of Science ®Google Scholar
• Tomson G, Vlad I. The need to look at antibiotic resistance from a health systems perspective. Ups J Med Sci; 2014;119:117–24.
   PubMed Web of Science ®Google Scholar
• Grundmann H. Towards a global antibiotic resistance surveillance system: a primer for a roadmap. Ups J Med Sci; 2014;119:87–95.
   PubMed Web of Science ®Google Scholar
• Zorzet A. Overcoming scientific and structural bottlenecks in antibacterial discovery and development. Ups J Med Sci; 2014;119:170–5.
   PubMed Web of Science ®Google Scholar
• Davies J. Antibiotic resistance and the golden age of microbiology. Ups J Med Sci; 2014;119:65–7.
   PubMed Web of Science ®Google Scholar
• Stålsby Lundborg C, Tamhankar AJ. Understanding and changing human behaviour—antibiotic mainstreaming as an approach to facilitate modification of provider and consumer behaviour. Ups J Med Sci; 2014;119:125–33.
   PubMed Web of Science ®Google Scholar
• So AD, Shah TA. New business models for antibiotic innovation. Ups J Med Sci; 2014;119:176–80.
   PubMed Web of Science ®Google Scholar
• Heyman G, Cars O, Bejarano M-T, Peterson S. Access, excess, and ethics—towards a sustainable distribution model for antibiotics. Ups J Med Sci; 2014;119:134–41.
   PubMed Web of Science ®Google Scholar